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Abstract DegR is a positive regulator for degradative enzyme
synthesis in Bacillus subtilis. The degR gene is transcribed by
RNA polymerase containing cD, and the level of its expression is
low in a mecA-deficient mutant. In a search for suppressors of
the mecA effect through mini-Tn10 transposon mutagenesis, a
lacR mutation designated lacR288 was discovered. The B.
subtilis lacR gene encodes the repressor for lacA which specifies
L-galactosidase, and therefore, inactivation of the lacR gene
results in overproduction of the enzyme. In the lacR288 mutant,
however, the expression of lacA was at a negligible level,
indicating that the repressor activity was not destroyed by the
mutation. The putative gene product of the lacR288-containing
gene is a 288-amino acid protein lacking the C-terminal 42 amino
acids of intact LacR and carries no extra amino acids derived
from the transposon sequence. The suppression by lacR288 of the
decreased degR expression in the mecA background was found to
be caused by an increase in the cD level as shown by Western blot
analysis. Furthermore, the increase was due to post-transcrip-
tional regulation of sigD, the gene encoding cD, as revealed by
using both transcriptional and translational sigD-lacZ fusions.
The lacR288 mutation had no effect on the stability of the cD
protein. Based on these results we conclude that the lacR288
mutation stimulates sigD expression at the translational level.
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1. Introduction
Bacillus subtilis cD is an alternative sigma factor involved in
transcription of the genes for motility [1] and certain autolysin
enzymes [2,3], ywcG encoding a protein related to energy me-
tabolism [4], and degR [5], a regulatory gene involved in deg-
radative enzyme synthesis [6,7]. These genes constitute the cD
regulon.
B. subtilis carries the gene for L-galactosidase that is en-
coded by lacA [8]. In laboratory conditions lacA is repressed
by LacR, which belongs to a group of DNA-binding repres-
sors including GalR and LacI, and most of the members of
this group contain a helix-turn-helix structure at their N-ter-
minal regions [9].
Competence development in B. subtilis is regulated mainly
by the level of the competence transcription factor ComK
[10,11], which is inactive when associated with MecA and
ClpC [12^14]. Inactivation of MecA results in overproduction
of ComK [10,11,15], leading to inhibition of the cD-dependent
degR expression [16]. Recently Liu and Zuber [17] demon-
strated that ComK positively regulates the transcription of
the £gM-containing operon that encodes an anti-cD factor
FlgM which binds to cD [18^21]. Thus the expression of the
cD regulon is negatively regulated by ComK.
Expression of degR is prevented by the overproduction of
ComK in a mecA-de¢cient mutant [16]. We expected, there-
fore, that factors involved in the process leading to the ex-
pression of degR could be found by employing a system in
which the recovery of degR expression is easily detected. We
used a transposon mini-Tn10 [22] for this purpose and dis-
covered two genes, degU and med, which were shown to be
positive regulators of comK in the mecA background [23,24].
In this paper we report analyses of a newly isolated trans-
poson mutation lacR288, which caused an increase in the
cellular level of cD at the translational level.
2. Materials and methods
2.1. Strains and plasmids
Strains used in this study are shown in Table 1. Construction of the
transcriptional sigDP-lacZ fusion was done by digestion of the PCR
fragment produced by using the sigD-H (5P-GTAAGCTTGA-
TATGCTGATAGAAGCGG-3P) and sigD-Bg (5P-GTAGATCTC-
TAAACGAGGCGTAGGTATC-3P) primers with HindIII and BglII,
followed by cloning of the resultant fragment between the HindIII
and BamHI sites of pMutin2 [25]. The constructed plasmid pSigDZ
was transformed into strain CU741 by Campbell-type recombination.
Disruption of the lacA gene was carried out as follows. First, a
PCR fragment containing lacA was prepared with the lacA-E
(5P-GTGAATTCAAGGAGGAGAATGTGATGTC-3P) and lacA-B
(5P-GTGGATCCATATCGAGCGGAGCATCAGC-3P) primers, di-
gested with HindIII and BamHI, and inserted between the HindIII
and BglII sites of pDH88 [26]. Second, the SmaI fragment carrying
the tetracycline resistance gene from pBEST309 [27] was inserted into
the SmaI site of the lacA gene. The inactivated lacA gene in the
resultant plasmid pLacA was introduced into the chromosome by a
double crossover event. Plasmid pEX lacking the sigD gene of pSigD
[18] was created by digestion of the latter plasmid with SalI and SphI,
followed by treatment with T4 DNA polymerase and DNA ligase.
The comKP-PlacZ fusion was obtained from Dubnau [10].
2.2. Medium and others
Cells were grown in Schae¡er’s sporulation medium [28]. L-Galac-
tosidase activities were measured as described previously [29].
3. Results
3.1. Isolation of lacR288 mutation that suppresses the
inhibitory e¡ect of mecA on degR expression
A transposon mutant in which degRP-PlacZ expression was
recovered was isolated after growing strain ODM40mak
(degRP-PlacZ mecA) harboring the mini-Tn10 delivery vector
pIC333 [22]. By out-cloning of the DNA region that carried
the transposon, a plasmid designated pLacR was obtained.
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When it was linearized and introduced into the chromosome
of strain ODM40 (degRP-PlacZ), followed by transformation
of the resultant strain with mecA-containing DNA, the trans-
formants formed blue colonies on a X-gal-containing plate,
indicating that the observed phenotype was indeed caused by
the transposon insertion mutation. A sequence analysis re-
vealed that Tn10 had inserted into codon 288 of lacR, which
is composed of 330 codons. An in-frame TGA stop codon had
been created at the transposon insertion site, showing that the
putative protein, LacR288, speci¢ed by lacR288 was a trun-
cated protein without extra amino acids at its C-terminal end
derived from the transposon.
The level of L-galactosidase directed by the degRP-PlacZ
fusion was greatly reduced in the mecA background (ODM40-
mak) as reported previously [23], whereas it was restored to
80% of the wild type level in the strain bearing both the mecA
and lacR288 mutations (MM42) (Fig. 1A). Strain ODM402
bearing lacR288 alone showed a slight increase in the expres-
sion of degRP-PlacZ (Fig. 1A). These results show that a dele-
tion of the C-terminal 42 amino acids from LacR caused an
increase in the expression of degR.
It was shown by Daniel et al. [8] that inactivation of lacR
results in overexpression of intrinsic lacA. Therefore, the pos-
sibility arose that the lacR288 mutation we isolated caused
overexpression of lacA and the L-galactosidase activity we
observed was derived from lacA but not from degRP-PlacZ.
This possibility was, however, excluded by the observation
that the levels of degRP-PlacZ expression were almost the
same in lacR288 mecA strains carrying either the intact or
disrupted lacA gene (data not shown).
These results show that the lacR288 gene product retains
the activity as the repressor of lacA and has a suppressive
e¡ect on the mecA inhibition of degRP-PlacZ.
Table 1
B. subtilis strains and plasmids used in this study
Strain or plasmid Relevant phenotype and description Reference or source
Strains
CU741 trpC2 LeuC7 [29]
ODM40 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) [5]
ODM40mak trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) mecA : :Kmr [24]
MM42 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) mecA : :Kmr lacR288(Tn10(Spr)) This work
ODM402 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) lacR288(Tn10(Spr)) This work
ODM403 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) lacA : :Tcr This work
SG83 trpC2 6(lacR : :Spr)83 [8]
ODM404 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) 6(lacR : :Spr)83 lacA : :Tcr This work
ODM405 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) mecA : :Kmr lacA : :Tcr This work
ODM406 trpC2 leuC7 amyE: :(degR3P-PlacZ(Cmr)) mecA : :Kmr 6(lacR : :Spr)83 lacA : :Tcr This work
OCM106 trpC2 leuC7 amyE: :(comK-lacZ(Cmr)) This work
OCM107 trpC2 leuC7 amyE: :(comK-lacZ(Cmr))lacR288(Tn10(Spr)) This work
OLM100 trpC2 leuC7 lacR288(Tn10(Spr)) This work
OLM101 trpC2 leuC7 lacA : :Tcr This work
ODS200 trpC2 leuC7 sigDP-PlacZ(Cmr) [5]
ODS201 trpC2 leuC7 sigDP-PlacZ(Cmr) lacR288(Tn10(Spr)) This work
ODS202 trpC2 leuC7 sigD-lacZ(Cmr) This work
ODS203 trpC2 leuC7 sigD-lacZ(Cmr) lacR288(Tn10(Spr)) This work
Plasmids
pIC333 Emr mini-Tn10 (Spr) [22]
pLacR pUC19 carrying lacR288 (Tn10(Spr)) This work
pLacA pDH88 carrying entire lacA in which Tc resistance gene is inserted This work
pSigDZ pMutIn2 carrying upstream and N-terminal portion of sigD This work
pSigD pDG148 carrying sigD [18]
pEx pDG148 derivative This work
Fig. 1. E¡ect of the lacR288 (A) and 6(lacR: :spc)83 (B) mutations
on degRP-PlacZ expression in mecA-de¢cient mutants. Numbers on
the x-axis represent the growth time in hours relative to the end of
the vegetative growth (T0). A: All strains carry degRP-PlacZ. a,
ODM40 (mecA); E, ODM40mak (mecA) ; F, MM42 (mecA
lacR288) ; b, ODM402 (mecA lacR288). B: All strains carry both
degRP-PlacZ and lacA. a, ODM403 (mecA) ; E, ODM405 (mecA) ;
F, ODM406 (mecA 6(lacR: :spc)83) ; b, ODM404 (mecA
6(lacR: :spc)83.
Fig. 2. E¡ect of the lacR288 mutation on the expression of comKP-
PlacZ translational fusion. Numbers on the x-axis represent the
growth time in hours relative to the end of the vegetative growth
(T0). a, OCM106 (comKP-PlacZ mecA lacR) ; b, OCM107 (comKP-
PlacZ mecA lacR288).
FEBS 22466 16-8-99
M. Ogura et al./FEBS Letters 457 (1999) 112^116 113
3.2. The e¡ect of lacR288 mutation on expression of comK and
cellular level of the cD protein
Based on the principle for the screening of suppressors, it is
possible that an isolated mutation a¡ects the expression of
either comK or sigD (see Section 1). We thus tested the e¡ect
of the lacR288 mutation on the expression of a comKP-PlacZ
translational fusion. Fig. 2 shows that the lacR288 mutation
did not a¡ect the expression of this fusion signi¢cantly. We
therefore conclude that the target of the lacR288 mutation is
not comK.
Next we determined the cD level in the cells carrying the
lacR288 mutation by Western blot analysis using anti-cD anti-
body. As shown in Fig. 3, the level of cD in the lacR strain
reached the peak at T0, which is in accordance with the ob-
servation that sigD expression becomes highest at around T0
[2,5]. A similar expression pattern was seen in the lacR288
strain, but the cD level was about threefold higher.
If the enhanced expression of sigD by the lacR288 mutation
is responsible for the restoration of degRP-PlacZ expression in
the mecA-de¢cient mutant, then overexpression of sigD
should overcome the inhibitory e¡ect of mecA. To test this
possibility we constructed ODM40 derivatives carrying either
pSigD in which the sigD gene is placed downstream of the
IPTG-inducible spac promoter [18] or its derivative, pEX, in
which the entire sigD gene has been deleted. Plasmid pSigD is
based on pUB110. Table 2 shows that in fact overexpression
of sigD overcame the mecA inhibition of degRP-PlacZ in an
IPTG-dependent manner. Addition of IPTG at as low as 0.01
mM was shown to have some suppressive e¡ect on mecA, and
at the highest concentration (0.3 mM) degRP-PlacZ expression
was increased about three times (Table 2). These results are in
agreement with the above observation that there was a three-
fold increase in the cD level in the lacR288 mutant. From
these results we conclude that the enhancing e¡ect of the
lacR288 mutation on degRP-PlacZ expression is due to the
enhanced expression of the sigD gene.
The expression of degRP-PlacZ was low in the experiments
in Table 2 as compared with those shown in Fig. 1. Similar
low level expression of degRP-PlacZ was observed when anoth-
er pUB110 derivative was used (data not shown), although the
reason is not known at present.
3.3. LacR regulates expression of sigD post-transcriptionally
To know how the elevated level of the cD protein is
achieved, we carried out epistatic analyses using both transla-
tional and transcriptional fusions of lacZ to sigD. It was
found that the expression of a sigDP-PlacZ translational fusion
was enhanced approximately two times in the lacR288 mutant
(Fig. 4A) as compared with that in the wild type strain. In
contrast to this result the expression of the sigDP-PlacZ
transcriptional fusion was not a¡ected signi¢cantly by the
lacR288 mutation (Fig. 4B). Furthermore, it was shown that
the stability of cD in vivo was not a¡ected by the lacR288
mutation (data not shown). From all of these results, we con-
clude that LacR288 is a translational regulator of the sigD
gene.
3.4. Intact LacR does not regulate degRP-PlacZ expression
The results described thus far show that LacR288 e¡ects
positive translational regulation on sigD. This would in turn
suggest that LacR is a negative regulator of sigD. If this was
the case, a lacR disruption mutation, 6(lacR: :spc)83, should
also suppress the mecA e¡ect on degRP-PlacZ. As shown in
Fig. 1B, the 6(lacR: :spc)83 mutation had no e¡ect on degRP-
Fig. 3. Quantitation of cD by Western blot analysis. Protein concen-
trations were adjusted by densitometric scanning of the protein
bands on SDS-PAGE gels after staining with Coomassie brilliant
blue. Detection of cD and anti-cD interaction was carried out by
BM Chemiluminescence Western Blotting Kit (Rabbit/Mouse)
(Boehringer Mannheim). The lower panel shows the quantitative
analysis of the cD bands as determined by densitometric analysis.
a, CU741 (lacR288) ; b, OLM100 (lacR288).
Table 2
Suppression of the inhibitory e¡ect of mecA on degRP-PlacZ by
overexpression of sigD
Host strain L-Galactosidase activity
IPTG 0 0.01 0.03 0.1 0.3 (mM)
plasmid
ODM40 pEX 26.6 ^a ^ a 23.5
ODM40 pSigD 23.1 25.2 29.7 42.7 47.3
ODM40ma pEX 6.6 ^ ^ ^ 7.0
ODM40ma pSigD 11.4 13.2 14.0 28.0 30.4
Cells were grown in Schae¡er’s sporulation medium. The L-galacto-
sidase activities expressed in Miller units are the peak values ob-
served at either T30.5 or T0. IPTG was added when the cell
growth reached 0.3 at OD600.
aExperiments were not carried out.
Fig. 4. E¡ect of the lacR288 mutation on the expression of transla-
tional and transcriptional fusions of sigD to lacZ. A: Translational
fusion: a, ODS200 (sigDP-PlacZ lacR) ; b, ODS201 (sigDP-PlacZ
lacR288). B: Transcriptional fusion: a, ODS202 (sigDP-PlacZ
lacR) ; b, ODS203 (sigDP-PlacZ lacR288).
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PlacZ expression in a lacA-de¢cient background, indicating
that LacR itself does not play any role in the regulation of
degR.
4. Discussion
We described in this paper a mini-Tn10 transposon muta-
tion, lacR288, which suppressed the inhibitory e¡ect of mecA
de¢ciency on degR. It appears that LacR288 has dual func-
tions. First, it may have a DNA-binding ability and functions
as a repressor for transcription of lacA as does the intact
LacR [8,9], since the lacR288 mutation retained the ability
to repress the expression of lacA. In contrast, Daniel et al.
[8] observed more than 100 times higher activity of LacA in a
B. subtilis JH642 derivative carrying the lacR-de¢cient muta-
tion 6(lacR: :spc)83. This di¡erence is not due to the strain
di¡erence, since a similar level of enhancement was observed
when we used a derivative of our standard strain CU741
carrying the same 6(lacR: :spc)83 mutation (data not
shown), indicating that the lacR288 and 6(lacR: :spc)83 mu-
tations are di¡erent in terms of the phenotypes that they
show. Second, LacR288 functions as a translational activator
of the sigD gene, which is contained in the £a/che operon [30].
It is not known whether LacR288 acts on translation of
sigD directly or indirectly. The possibility, however, could
be ruled out that LacR288 would derepress expression of an
unknown gene(s) that is required for translation of the sigD
gene, since the truncated LacR288 protein still has the repres-
sor activity for lacA (and therefore DNA-binding activity),
and it might be unlikely that the protein has lost the repressor
activity for this hypothetical gene.
Apparently intact LacR itself does not regulate sigD, since a
disruption by the 6(lacR: :spc)83 mutation had no e¡ect on
the expression of either sigD or degR. It could be speculated,
however, that LacR has an activity to regulate translation of
sigD through its N-terminal domain and that the C-terminal
domain of LacR inhibits this function. B. subtilis LacR shows
the highest homology to Escherichia coli EbgR in amino acid
sequence [8]. The N-terminal regions of the LacI-GalR family
proteins have been shown to have a DNA-binding activity,
while the middle regions carry both dimerization and e¡ector-
binding activities. The role of the C-terminal regions is not
known except for LacI [9]. Intramolecular inhibition of a cer-
tain function by another region of the same protein is exem-
pli¢ed in the case of c70 [31]. Moreover, several proteins with
a helix-turn-helix structure including E. coli LacI have been
shown to bind 10Sa RNA [32]. By analogy with these ¢ndings
we infer that LacR also has an RNA-binding activity and that
truncation of a certain C-terminal region of LacR results in
alteration of the speci¢city for RNA. Thus, LacR288 lacking
the C-terminal 42 amino acids could work as a translational
regulator of sigD possibly through binding to its mRNA.
That a speci¢c DNA-binding protein also works as a transla-
tional regulator is not unprecedented. For example, NtrC, a
DNA-binding protein, has been shown to work as a transla-
tional activator of the nifR3 operon in Rhodobacter capsulatus
[33]. Moreover, B. subtilis SinR, a sequence-speci¢c DNA-
binding protein, regulates the expression of comS at the trans-
lational level ; the comS gene is located in the middle of the
27-kb srf mRNA and directs a positive regulator of ComK
[14,34,35]. In eukaryotes, the bcd homeodomain protein in
Drosophila binds to mRNA and functions at the translational
level [36]. The precise mechanisms underlying these observa-
tions, however, remains to be elucidated.
The biological implication of the derepression of sigD by
LacR288 remains unknown. However, the fact that a new
function was identi¢ed in a LacR mutant may be important
from an evolutionary point of view, since the observation that
a hidden function was found in LacR might be extended to
the other members of the LacI-GalR group.
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